Exploring Heart Rate Variability, EEG Pattern, and Corticomuscular Coherence After Cervical Sagittal Alignment Restoration

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorUniversity of Sharjah

About this trial

The goal of this Randomized clinical trial is to learn about how fixing neck curvature and head posture right away affects heart rate, brainwaves, and muscle coordination in college athletes. The main question it aims to answer:

\- Whether forward head posture (FHP) may play a crucial role in affecting heart rate variability, brainwaves, and muscle coordination.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Anterior head translation (AHT) >15 mm

Absolute rotatory angle C2 to C7 is <25°

Athletic student

Disqualifiers

Inflammatory joint disease or other systemic pathologies

Prior history of overt injury and surgery relating to the musculoskeletal system, or disorder related to the spine and extremities

Musculoskeletal pain in the previous three months.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Denneroll cervical traction orthodontic

    Device

    The duration of each session will start at approximately three minutes and increase by one minute per session until reaching the goal of 20 minutes per session. The intervention will be repeated three times per week for 10 weeks in the supervised setting.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Denneroll GroupExperimental treatment 1 intervention
Group B: Wait ListOther 1 intervention

Trial outcomes

Primary outcomes

1

Cervical Sagittal Alignment Radiographs

The change of cervical lordosis from the absolute rotatory angle C2-7.

Time frame
Baseline (pre-treatment), week 10 (upon completion) and after 6 months
2

Cervical Sagittal Alignment Radiographs

The amount of the change in the anterior head translation from the horizontal offset of the posterior superior body corner of C2 relative to the vertical line.

Time frame
Baseline (pre-treatment), week 10 (upon completion) and after 6 months

Secondary outcomes

1

Heart rate Variability (HRV) physiological parameter

The change in Heart rate through Electrocardiographic recordings (ECG) will be monitored using a Nexus-10 physiologic monitoring system. Recordings will be made simultaneously through three separate channels. The ground electrode will be placed below the left clavicle, the cathode (-) below the right clavicle and the anode (+) will be placed on the third rib, in line with the ground. HRV time parameter will be calculated from respiratory rate (RR) intervals (Standard deviation of the normal to normal intervals (SDNN), Root-mean-square of the successive normal sinus RR interval difference (RMSSD) and the percentage of absolute differences between successive normal RR intervals that exceed 50 ms (pNN50)). HRV frequency domain variable will include total power, high frequency (HF) and low frequency (LF) power (measured in ms2) and LF:HF ratio were derived from spectral analysis of successive R-R intervals.

Time frame
Baseline (pre-treatment), week 10 (upon completion) and after 6 months
2

Corticomuscular Coherence

The change in the ratio between Muscle activity through Electromyography (EMG) and brain waves through Electroencephalograph (EEG)

Time frame
Baseline (pre-treatment), week 10 (upon completion) and after 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: